When you are creating a sales-based forecast there can be a wide range of sophisticated forecasting methodologies available to you.

If you are forecasting for an asset across multiple tumour types, forecasting using biomarkers may be a favourable approach for you.

An article written by David James, IPI - International Pharmaceutical Industry

This post will look at Epidemiology Forecasting, and running a risk analysis on consolidated revenues.

This post will look at Oncology Forecasting, and accounting for chronic patients in your forecast.